Skip to Main Content

A team of biotech veterans say they have raised $3 billion to create a continent-spanning company that will aim to battle disease by reprogramming the fundamental machinery of living cells.

It appears to be the largest venture capital fundraising effort in biotech history, based on a survey of data from Pitchbook.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

Create a display name to comment

This name will appear with your comment